ReviewFrontiers in immunology2025

Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development.

Abdullah R Alrasheed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.